Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Molecular imaging of hypoxia with radiolabelled agents
2009
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Head and neck squamous cell carcinoma
2020 Standout
Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
2008
Molecular imaging in drug development
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
2006
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Image-guided radiotherapy: from current concept to future perspectives
2012
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Serial Hypoxia Imaging With 99mTc-HL91 SPECT to Predict Radiotherapy Response in Nonsmall Cell Lung Cancer
2006
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
Can small animal imaging accelerate drug development?
2002
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
2010
Treatment-time-dependence models of early and delayed radiation injury in rat small intestine
2000
Imaging oxygenation of human tumours
2006
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Use of new imaging techniques to predict tumour response to therapy
2010
Meta-DiSc: a software for meta-analysis of test accuracy data
2006 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
New approaches for imaging tumour responses to treatment
2008
Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
2005
PET imaging of cellular proliferation
2005
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
2007
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
2010
Immunological Functions of the Omentum
2017 Standout
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer
2007
Hypoxia-inducible factor 1 and breast cancer metastasis
2015 StandoutNobel
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival
2007
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Imaging and cancer: A review
2008
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
HIF and the Lung
2011 StandoutNobel
Methods for Noninvasive Imaging of Tissue Hypoxia
2007
Imaging in staging of malignant lymphoma: a systematic review
2007
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy
2010
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
2006
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues
2012
An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers
2006
Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography
2008
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
2005
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Sigma Receptors and Cancer
2004
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Selection of Response Criteria for Clinical Trials of Sarcoma Treatment
2008
Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
2004
Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum
2006
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Redistribution of Nucleoside Transporters to the Cell Membrane Provides a Novel Approach for Imaging Thymidylate Synthase Inhibition by Positron Emission Tomography
2006
HPV, hypoxia and radiation response in head and neck cancer
2018
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901
2007
Works of Helmut Dittmann being referenced
[ 18 F]FLT PET for diagnosis and staging of thoracic tumours
2003
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma
2001
PET with [ 18 F]fluorothymidine for imaging of primary breast cancer: a pilot study
2004
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
2006
Early changes in [ 18 F]FLT uptake after chemotherapy: an experimental study
2002
Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
2005
In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA)
1999
Rhenium-188 for inhibition of human aortic smooth muscle cell proliferation
2001
Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
2006
Expression of the proliferation marker K i‐67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas
2012
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
2005